Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jan 02, 2024

SELL
$121.0 - $257.67 $968 - $2,061
-8 Reduced 50.0%
8 $1.7 Million
Q1 2021

Jan 02, 2024

SELL
$112.98 - $319.93 $564 - $1,599
-5 Reduced 23.81%
16 $2.9 Million
Q3 2020

Jan 02, 2024

BUY
$79.44 - $178.51 $1,668 - $3,748
21 New
21 $2.28 Million
Q4 2016

Jan 03, 2024

SELL
N/A
-1,000 Closed
0 $0
Q2 2016

Jan 03, 2024

BUY
N/A
1,000
1,000 $7.27 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.